Skip to main content
Clinical Trials/NL-OMON32311
NL-OMON32311CompletedPhase 3

Differences in maternal temperature and saturation after administration of remifentanil PCA or epidural analgesia during labor - maternal temperature and oxygen saturation during delivery

eids Universitair Medisch Centrum0 sites175 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
175

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • * Age *18 years
  • * Between 37-42 weeks of gestation
  • * Singleton pregnancy
  • * ASA physical status I or II

Exclusion Criteria

  • * Prior administration of regional of opioid analgesia (during this delivery).
  • * Morbid obesity (BMI * 40 kg/m2)
  • * Drug allergy: history of hypersensitivity to opioid or local anesthetic substances
  • * High risk pregnancy: including severe asthma (daily use of medication), insulin dependent diabetes, severe pre-eclampsia (proteinuria * 5 grams)
  • * Use of antibiotics during delivery
  • * Initial maternal SpO2 of less than 98%
  • * Initial maternal temperature of 38°C or higher.
  • * Cervical dilation of > 7 cm
  • * Ruptured membranes for more than 24 hours at time of inclusion
  • * Contraindication for epidural analgesia

Investigators

Similar Trials